COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00073879
Brief Title: Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation

First Submitted : December 10, 2003
First Submitted that Met QC Criteria : December 10, 2003
First Posted : December 11, 2003 (Estimate)

Last Update Submitted that Met QC Criteria : January 27, 2015
Last Update Posted : January 29, 2015 (Estimate)